NMPA Approval

Moxifloxacin Hydrochloride and Sodium Chloride Injection

Approval Number

国药准字H20234176

Company安徽博诺美科生物医药有限公司

Registration Date

September 19, 2023

Drug Information

Generic Name

盐酸莫西沙星氯化钠注射液

Dosage Form

注射剂

Strength

250ml∶盐酸莫西沙星（按C₂₁H₂₄FN₃O₄计）0.4g与氯化钠2.0g

Drug Type

化学药品

Registration Date

September 19, 2023

Company Information

Applicant Company

Company Name安徽博诺美科生物医药有限公司

Company Address

安徽省合肥市高新区柏堰湾路2600号

Manufacturing Company

Company Name上海华源安徽锦辉制药有限公司

Company Address

安徽省阜阳市颍州区莲花路160号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.